BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
HealthcareDivestiture
BriaPro Therapeutics→BriaCell Therapeutics
Mar 31, 2026
Tracking 1 M&A deal by BriaPro Therapeutics.
BriaPro Therapeutics→BriaCell Therapeutics
Mar 31, 2026